Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-007809
Filing Date
2019-08-09
Accepted
2019-08-09 08:03:32
Documents
68
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ardx-20190630x10q.htm 10-Q 2401096
2 EX-31.1 ardx-20190630ex311396afe.htm EX-31.1 22351
3 EX-31.2 ardx-20190630ex312b1ab6a.htm EX-31.2 22335
4 EX-32.1 ardx-20190630ex321a0b720.htm EX-32.1 16881
  Complete submission text file 0001558370-19-007809.txt   8002429

Data Files

Seq Description Document Type Size
5 EX-101.INS ardx-20190630.xml EX-101.INS 1805190
6 EX-101.SCH ardx-20190630.xsd EX-101.SCH 45953
7 EX-101.CAL ardx-20190630_cal.xml EX-101.CAL 58958
8 EX-101.DEF ardx-20190630_def.xml EX-101.DEF 182280
9 EX-101.LAB ardx-20190630_lab.xml EX-101.LAB 355784
10 EX-101.PRE ardx-20190630_pre.xml EX-101.PRE 323000
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36485 | Film No.: 191011361
SIC: 2834 Pharmaceutical Preparations